TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16029223

Group type: EXPERIMENTAL
Intervention: Direct laryngoscopy with a Macintosh laryngoscope
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lingual traction with jaw thrust
Number of subjects: 40
Study: 12590903

Group type: EXPERIMENTAL
Intervention: Cardiogenic shock patients
Number of subjects: 6676

Group type: EXPERIMENTAL
Intervention: Early shock development (days 1-2)
Number of subjects: 6676

Group type: EXPERIMENTAL
Intervention: Intermediate or late shock development (>80%)
Number of subjects: 6676

Group type: COMPARATOR
Intervention: Non-shock patients
Number of subjects: 6676

Group type: EXPERIMENTAL
Intervention: 30-day survivors with cardiogenic shock
Number of subjects: 6676
Study: 10850381

Group type: EXPERIMENTAL
Intervention: Filgrastim (r-metHuG-CSF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8947979

Group type: EXPERIMENTAL
Intervention: Propranolol 60 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol 120 mg/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1901782

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7006425

Group type: EXPERIMENTAL
Intervention: EEA stapler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional hand-sewn technique
Number of subjects: 0
Study: 30624403

Group type: EXPERIMENTAL
Intervention: Tissue reduction technique (split skin graft or linear incision)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Tissue preservation technique
Number of subjects: 263
Study: 30027912

Group type: EXPERIMENTAL
Intervention: Topical minoxidil 5% solution plus low-level light therapy twice per day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical minoxidil 5% solution with a laser comb system turned off (placebo)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Topical minoxidil 5% solution plus low-level light therapy
Number of subjects: 50
Study: 26468161

Group type: EXPERIMENTAL
Intervention: Haem arginate
Number of subjects: 14

Group type: COMPARATOR
Intervention: Vehicle (l-arginine)
Number of subjects: 14
Study: 25343263

Group type: EXPERIMENTAL
Intervention: Corneal collagen cross-linking (CXL)
Number of subjects: 104
Study: 23095424

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment
Number of subjects: 56
Study: 19953262

Group type: COMPARATOR
Intervention: Visual feedback gain of 0.5-4 pixels/N
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Visual feedback gain of 64-1,424 pixels/N
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Visual feedback gain increase
Number of subjects: 14
Study: 17940103

Group type: EXPERIMENTAL
Intervention: Higher-intensity, individualized treadmill training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lower-intensity, generalized treadmill training
Number of subjects: 30
Study: 16088848

Group type: EXPERIMENTAL
Intervention: Candesartan (16 mg, increased to 32 mg after one month)
Number of subjects: 5231
Study: 12419426

Group type: EXPERIMENTAL
Intervention: Conventional or accelerated radiotherapy (RT) with or without concomitant carboplatin
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Concomitant cisplatin, etoposide, and RT
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Concomitant carboplatin, 5-fluorouracil, and RT
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: T stage (T1, T2, T3, T4)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Multifactor analysis using Cox proportional hazards regression analysis
Number of subjects: 243
Study: 11273369

Group type: EXPERIMENTAL
Intervention: Clinical Reasoning Exercise (CRE) scored by tutors
Number of subjects: 102

Group type: COMPARATOR
Intervention: Crossover tutor's ratings
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: CRE
Number of subjects: 102
Study: 9745827

Group type: EXPERIMENTAL
Intervention: Baerveldt glaucoma implant
Number of subjects: 22
Study: 10122606

Group type: EXPERIMENTAL
Intervention: Nursing home care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Geriatric ward care
Number of subjects: 0
Study: 3311145

Group type: EXPERIMENTAL
Intervention: Swallowing without chewing
Number of subjects: 24

Group type: COMPARATOR
Intervention: Chewing food
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Administration of viscous polysaccharides or 'slow-release' carbohydrates
Number of subjects: 24
Study: 29652929

Group type: EXPERIMENTAL
Intervention: MVA vaccine (Groups 1-3)
Number of subjects: 4005

Group type: COMPARATOR
Intervention: Placebo (Group 4)
Number of subjects: 4005
Study: 27743130

Group type: EXPERIMENTAL
Intervention: Fermented garlic extract (FGE), 2 sachets/day for 12 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo, 2 sachets/day for 12 weeks
Number of subjects: 75
Study: 25613811

Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 200

Group type: COMPARATOR
Intervention: Latanoprost-timolol fixed combination (LTFC)
Number of subjects: 200
Study: 23941362

Group type: EXPERIMENTAL
Intervention: Normoglucidic low‐calorie diet (NGLCD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Low‐fat diet (LFD)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both diets (NGLCD and LFD)
Number of subjects: 120
Study: 21906390

Group type: EXPERIMENTAL
Intervention: Active treatment (HFCWO)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 52
Study: 18196414

Group type: EXPERIMENTAL
Intervention: Polished stems (165 hips)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Satin stems (123 hips)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Matte stems (145 hips)
Number of subjects: 395
Study: 17015818

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER (37.5-300 mg/d)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER
Number of subjects: 329
Study: 14692709

Group type: EXPERIMENTAL
Intervention: Liverman capsule
Number of subjects: 24

Group type: COMPARATOR
Intervention: Legalon capsule
Number of subjects: 24

Group type: COMPARATOR
Intervention: Silymarin tablet
Number of subjects: 24
Study: 11053332

Group type: EXPERIMENTAL
Intervention: High-intensity endurance training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-intensity endurance training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 8922657

Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T3) 20 micrograms three times daily for 7 days
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T3) stimulation
Number of subjects: 29
Study: 1372418

Group type: EXPERIMENTAL
Intervention: AC pacemaker (accelerometer-based)
Number of subjects: 20

Group type: COMPARATOR
Intervention: PZ pacemaker (piezoelectric crystal)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intrinsic HR
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: AC pacemaker (during bicycle ergometry)
Number of subjects: 20

Group type: COMPARATOR
Intervention: PZ pacemaker (during bicycle ergometry)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: AC pacemaker (during stair climbing)
Number of subjects: 20

Group type: COMPARATOR
Intervention: PZ pacemaker (during stair climbing)
Number of subjects: 20
Study: 31308348

Group type: EXPERIMENTAL
Intervention: Evocalcet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cinacalcet
Number of subjects: 0
Study: 27889937

Group type: EXPERIMENTAL
Intervention: Smoking in the home
Number of subjects: 1491

Group type: EXPERIMENTAL
Intervention: Sharing a latrine with one other household
Number of subjects: 1491

Group type: EXPERIMENTAL
Intervention: Sharing a latrine with more than one household
Number of subjects: 1491
Study: 26481870

Group type: EXPERIMENTAL
Intervention: Dance movement based intervention
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Stretching and exercise intervention
Number of subjects: 201

Group type: COMPARATOR
Intervention: No intervention waitlist-control group
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Both intervention groups
Number of subjects: 201
Study: 23391367

Group type: EXPERIMENTAL
Intervention: Single doses of arbidol (0.2 g, 0.4 g, 0.8 g)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Multiple doses of arbidol (0.2 g, 3 times a day for 7 days)
Number of subjects: 12
Study: 21853611

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 24

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 24
Study: 19734180

Group type: EXPERIMENTAL
Intervention: Behavioural family management for 18 mothers
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Psychoeducation for 19 mothers
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard care for 18 mothers
Number of subjects: 55
Study: 17439903

Group type: EXPERIMENTAL
Intervention: 11 mug of subcutaneously injected interferon beta 1a (IFNp‐1 a)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 33 mug of subcutaneously injected interferon beta 1a (IFNp‐1 a)
Number of subjects: 62
Study: 15887505

Group type: COMPARATOR
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:200,000 epinephrine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine
Number of subjects: 20
Study: 12841306

Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of Vitamin C and E
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 9732305

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (7000 microg retinol equivalents weekly)
Number of subjects: 29000

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (7000 microg retinol equivalents weekly)
Number of subjects: 29000

Group type: EXPERIMENTAL
Intervention: Vitamin A and beta-carotene supplementation
Number of subjects: 29000

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 29000
Study: 7666265

Group type: EXPERIMENTAL
Intervention: Heparin intake (mean 83.5 units/kg/day)
Number of subjects: 862

Group type: COMPARATOR
Intervention: No heparin intake (mean 59.4 units/kg/day)
Number of subjects: 862
Study: 2773833

Group type: EXPERIMENTAL
Intervention: Moderate nicotine dose (15 micrograms/kg body wt)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low nicotine dose (7.5 micrograms/kg body wt)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (0 micrograms)
Number of subjects: 18
Study: 61951

Group type: EXPERIMENTAL
Intervention: Benetazone Spofa (trimethazone) 1000 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phenylbutazone 600 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benetazone Spofa (trimethazone)
Number of subjects: 0
Study: 30027510

Group type: EXPERIMENTAL
Intervention: High tie (HT)
Number of subjects: 331
Study: 28392176

Group type: EXPERIMENTAL
Intervention: Ketorolac 4 times a day (qid) + 1% prednisolone acetate (PA) every hour while awake (q1hWA)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ketorolac 4 times a day (qid)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ketorolac 4 times a day (qid) + 1% prednisolone acetate (PA) every hour while awake (q1hWA) after crossover
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ketorolac 4 times a day (qid) after crossover
Number of subjects: 42
Study: 26905330

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by radical surgery (NACT-RS)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Radical surgery alone (RS)
Number of subjects: 800
Study: 24984991

Group type: EXPERIMENTAL
Intervention: Combined calcium and iron (700 mg Ca as calcium carbonate plus 30 mg Fe as ferrous sulfate)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Iron supplementation alone (30 mg Fe as ferrous sulfate)
Number of subjects: 195
Study: 23150095

Group type: EXPERIMENTAL
Intervention: Direct application of fibroblast growth factor (FGF)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Fibroblast growth factor (FGF) via Gelfoam
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conservative treatment (observation)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Direct application of fibroblast growth factor (FGF) and FGF via Gelfoam
Number of subjects: 94
Study: 19950575

Group type: EXPERIMENTAL
Intervention: PAS group (aspirin 100 mg, atorvastatin 10 mg, probucol 0.25 g daily)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Control group (aspirin 100 mg, atorvastatin 10 mg daily)
Number of subjects: 436
Study: 17964883

Group type: EXPERIMENTAL
Intervention: Neutral wrist and MCP splint
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wrist cock-up splint
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Neutral wrist and MCP splint with exercises
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wrist cock-up splint with exercises
Number of subjects: 61
Study: 14692903

Group type: EXPERIMENTAL
Intervention: PGB, 150 mg/day
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: PGB, 600 mg/day
Number of subjects: 287

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study: 11208823

Group type: EXPERIMENTAL
Intervention: 12 monthly cycles of adjuvant CMF chemotherapy
Number of subjects: 386

Group type: COMPARATOR
Intervention: No further treatment after radical mastectomy
Number of subjects: 386
Study: 11360566

Group type: EXPERIMENTAL
Intervention: Feiyan Mixture (FYM)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 128
Study: 8092756

Group type: EXPERIMENTAL
Intervention: Buflomedil infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (isotonic saline) infusion
Number of subjects: 0
Study: 3382042

Group type: EXPERIMENTAL
Intervention: Blue nail polish
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Green nail polish
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Black nail polish
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Purple nail polish
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Red nail polish
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Brown-red nail polish
Number of subjects: 14
Study: 31727768

Group type: EXPERIMENTAL
Intervention: BCL2 alterations
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: BCL2 translocations
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: BCL2 gene and protein expression levels
Number of subjects: 499
Study: 30937560

Group type: EXPERIMENTAL
Intervention: Intraoperative saddle nose deformity observed in patients undergoing septoplasty.
Number of subjects: 2106

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 2106

Group type: EXPERIMENTAL
Intervention: Severe caudal septal deviation
Number of subjects: 2106

Group type: EXPERIMENTAL
Intervention: Intraoperative finding of septal cartilage fracture
Number of subjects: 2106

Group type: COMPARATOR
Intervention: Control group (216 patients with no intraoperative saddle nose deformity)
Number of subjects: 2106
Study: 28633777

Group type: EXPERIMENTAL
Intervention: Superficial corticosteroid injection
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Deep corticosteroid injection
Number of subjects: 30
Study: 25892354

Group type: EXPERIMENTAL
Intervention: Thai foot massage
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 23790815

Group type: EXPERIMENTAL
Intervention: Expressive writing for 20 min over three consecutive days about their deepest thoughts and feelings surrounding an emotional event (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control condition (n=20)
Number of subjects: 40
Study: 22039193

Group type: EXPERIMENTAL
Intervention: Weight gain from birth to 3 months
Number of subjects: 10495

Group type: EXPERIMENTAL
Intervention: Weight gain from 3 months to 1 year
Number of subjects: 10495

Group type: EXPERIMENTAL
Intervention: Weight gain from 1 to 5 years
Number of subjects: 10495

Group type: EXPERIMENTAL
Intervention: Birthweight
Number of subjects: 10495
Study: 19379121

Group type: EXPERIMENTAL
Intervention: Recombinant FSH
Number of subjects: 0
Study: 17291932

Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intravenous diuretics
Number of subjects: 200
Study: 16060821

Group type: EXPERIMENTAL
Intervention: Spanish and English Neuropsychological Assessment Scales (SENAS)
Number of subjects: 527
Study: 12120771

Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐Purpose Plus and silver amalgam (G2)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Silver amalgam (G1)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Silver amalgam (G3)
Number of subjects: 3
Study: 9925061

Group type: EXPERIMENTAL
Intervention: n of 1 trials (theophylline therapy)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard practice (theophylline therapy)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: n of 1 trials (theophylline treatment)
Number of subjects: 68
Study: 8542870

Group type: EXPERIMENTAL
Intervention: Hirudin (DG I: bolus 0.1 mg.kg‐1 and continuous infusion 0.06 mg.kg‐1.h‐1)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Hirudin (DG II: bolus 0.2 mg.kg‐1.h‐1)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Hirudin (DG III: bolus 0.4 mg.kg‐1 with 0.15 mg.kg‐1.h‐1)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Heparin as an adjunct to streptokinase and aspirin (control group)
Number of subjects: 117
Study: 2278545

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (after 8 hours)
Number of subjects: 487

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 487
Study: 6263115

Group type: EXPERIMENTAL
Intervention: Marijuana intoxication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 30537083

Group type: EXPERIMENTAL
Intervention: Fimasartan (60 mg once a day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Amlodipine (5 mg once a day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fimasartan
Number of subjects: 50

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 50
Study: 28691132

Group type: EXPERIMENTAL
Intervention: Topical pure emu oil
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 73
Study: 25445556

Group type: EXPERIMENTAL
Intervention: Salvage radiation therapy (SRT) at 66 Gy to the prostate bed, median 86 days after RP
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Salvage radiation therapy (SRT)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Undetectable PSA after RP (arms A + B)
Number of subjects: 388
Study: 23806773

Group type: EXPERIMENTAL
Intervention: Intravenous zoledronic acid (ZA) 4 mg administered within 28 days pre-HCT and at 3 and 6 months after HCT
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Intravenous zoledronic acid (ZA)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (calcium carbonate and vitamin D supplements)
Number of subjects: 61
Study: 21465940

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (HS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Electrocautery (EC)
Number of subjects: 60
Study: 18203681

Group type: EXPERIMENTAL
Intervention: Home safety intervention (standardized health visitor safety consultation and free or low-cost safety equipment fitted in the home)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 16888706

Group type: EXPERIMENTAL
Intervention: Doppler-optimized fluid management (additional colloid boluses based on Doppler assessment)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (perioperative fluid at the discretion of the anaesthetist)
Number of subjects: 108
Study: 15231038

Group type: EXPERIMENTAL
Intervention: Carbopol 971P
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbopol 71G
Number of subjects: 0

Group type: COMPARATOR
Intervention: Buffered and unbuffered media
Number of subjects: 0
Study: 11709314

Group type: EXPERIMENTAL
Intervention: Ritonavir-saquinavir (400 mg b.i.d.)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Ritonavir (600 mg b.i.d.)
Number of subjects: 47
Study: 9381901

Group type: EXPERIMENTAL
Intervention: Closed retrograde locked intramedullary nailing using the Russell‐Taylor nail
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Closed retrograde locked intramedullary nailing using the Synthes prototype unreamed humeral nail
Number of subjects: 100

Group type: COMPARATOR
Intervention: Closed retrograde locked intramedullary nailing
Number of subjects: 100
Study: 7962373

Group type: EXPERIMENTAL
Intervention: HMG with intra-uterine insemination (IUI)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: GnRHa/HMG with IUI
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: HMG with IUI
Number of subjects: 91
Study: 3131251

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg b.i.d. (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Penicillin V 2 g t.i.d. (n = 40)
Number of subjects: 80
Study: 29657147

Group type: EXPERIMENTAL
Intervention: Subcutaneous Abatacept (ABA) 125 mg/wk
Number of subjects: 1385

Group type: COMPARATOR
Intervention: Intravenous Abatacept (ABA)
Number of subjects: 1385
Study: 28511482

Group type: EXPERIMENTAL
Intervention: ketofol (25 mg ketamine plus 25 mg propofol)
Number of subjects: 92

Group type: COMPARATOR
Intervention: placebo (saline)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: ketamine (0.25 mg/kg)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: propofol (0.25 mg/kg)
Number of subjects: 92
Study: 25698152

Group type: EXPERIMENTAL
Intervention: Low-lipid diet
Number of subjects: 83

Group type: COMPARATOR
Intervention: Normal-lipid diet
Number of subjects: 83
Study: 23325368

Group type: EXPERIMENTAL
Intervention: 100 mg sumatriptan
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 50 mg sumatriptan
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sumatriptan (both doses)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SPST (independent of treatment)
Number of subjects: 36
Study: 21654430

Group type: EXPERIMENTAL
Intervention: 6-month individual-based lifestyle intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 19564474

Group type: EXPERIMENTAL
Intervention: hrIFN-alpha 5,000 units
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: hrIFN-alpha 30,000 units
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88